Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-721-3468
Dr. Schneider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Logan Schneider is a neurologist in Redwood City, CA and is affiliated with VA Palo Alto Heath Care. He received his medical degree from University of Florida College of Medicine and has been in practice since 2015. He specializes in sleep medicine and is experienced in sleep medicine, continuous positive airway pressure, insomnia, narcolepsy, and parasomnias. He has more than 80 publications and over 500 citings.
Education & Training
Stanford University School of MedicinePost-Doctoral Fellowship, 2015 - 2018
Stanford Health Care-Sponsored Stanford UniversityFellowship, Sleep Medicine, 2014 - 2015
Johns Hopkins UniversityResidency, Neurology, 2011 - 2014
University of FloridaInternship, Internal Medicine, 2010 - 2011- University of Florida College of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2014 - 2026
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Sleep Medicine
Publications & Presentations
PubMed
- 1 citationsCurrent knowledge on the pathophysiology of idiopathic hypersomnia and potential mechanisms of action for low-sodium oxybate treatment.Logan D Schneider, Alyssa Cairns, Chad Ruoff, Richard K Bogan
Journal of Clinical Sleep Medicine. 2025-07-01 - A minimal clinically important difference for the sleep inertia visual analog scale in idiopathic hypersomnia.Richard K Bogan, Douglas S Fuller, Marisa Whalen, Cristina Casstevens, Logan D Schneider
Journal of Clinical Sleep Medicine. 2025-07-01 - 1 citationsCircadian rhythm of heart rate and activity: A cross-sectional study.Aravind Natarajan, Karla Gleichauf, Maryam Khalid, Conor Heneghan, Logan Douglas Schneider
Chronobiology International. 2025-01-01
Authored Content
- AAN 2021 Study Preview: The Exciting World of SleepApril 2021
- Next in Sleep Medicine: Debates on Sleep TechJune 2019
Press Mentions
Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych CongressesSeptember 22nd, 2025- Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych CongressesSeptember 22nd, 2025
- Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych CongressesSeptember 22nd, 2025
- Join now to see all
Grant Support
- MULTI-INSTITUTIONAL TRAINING IN GENETIC/GENOMIC APPROACHES TO SLEEP DISORDERSNational Institutes of Health - National Heart, Lung, and Blood Institute2015–2018
Committees
- Chair, American Academy of Sleep Medicine Research Career Development Committee 2024 - Present
- Chair, American Academy of Neurology Graduate Education Subcommittee 2022 - Present
- Vice-chair, American Academy of Sleep Medicine Research Career Development Committee 2021 - 2024
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
